Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-25

FDA Approved: SPIRONOLACTONE — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Camber Pharmaceuticals' generic spironolactone under an original application (ANDA 217761).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spironolactone (spironolactone)

Snippet

ORIG AP for SPIRONOLACTONE (SPIRONOLACTONE)